Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News

Table of Contents

CCR Translations

  • CCR Translations
    Biomarkers in GIST: Partly Ready for Prime-Time Use
    Charles D. Blanke
    Clin Cancer Res September 15 2009 15 (18) 5603-5605; DOI:10.1158/1078-0432.CCR-09-1563

  • CCR Translations
    Prevention of Progression in Monoclonal Gammopathy of Undetermined Significance
    S. Vincent Rajkumar
    Clin Cancer Res September 15 2009 15 (18) 5606-5608; DOI:10.1158/1078-0432.CCR-09-1575

Molecular Pathways

  • Molecular Pathways
    Inhibition of ALK Signaling for Cancer Therapy
    Yael P. Mossé, Andrew Wood and John M. Maris
    Clin Cancer Res September 15 2009 15 (18) 5609-5614; DOI:10.1158/1078-0432.CCR-08-2762

  • Molecular Pathways
    The Multifaceted Role of MTDH/AEG-1 in Cancer Progression
    Guohong Hu, Yong Wei and Yibin Kang
    Clin Cancer Res September 15 2009 15 (18) 5615-5620; DOI:10.1158/1078-0432.CCR-09-0049

CCR Special Focus

  • CCR Special Focus
    From the Editor
    Susan E. Bates
    Clin Cancer Res September 15 2009 15 (18) 5621-5621; DOI:10.1158/1078-0432.CCR-15-18-INT

  • CCR Special Focus
    Lung Cancer in Never Smokers: A Call to Action
    Charles M. Rudin, Erika Avila-Tang and Jonathan M. Samet
    Clin Cancer Res September 15 2009 15 (18) 5622-5625; DOI:10.1158/1078-0432.CCR-09-0373

  • CCR Special Focus
    Lung Cancer in Never Smokers: Clinical Epidemiology and Environmental Risk Factors
    Jonathan M. Samet, Erika Avila-Tang, Paolo Boffetta, Lindsay M. Hannan, Susan Olivo-Marston, Michael J. Thun and Charles M. Rudin
    Clin Cancer Res September 15 2009 15 (18) 5626-5645; DOI:10.1158/1078-0432.CCR-09-0376

  • CCR Special Focus
    Lung Cancer in Never Smokers: Molecular Profiles and Therapeutic Implications
    Charles M. Rudin, Erika Avila-Tang, Curtis C. Harris, James G. Herman, Fred R. Hirsch, William Pao, Ann G. Schwartz, Kirsi H. Vahakangas and Jonathan M. Samet
    Clin Cancer Res September 15 2009 15 (18) 5646-5661; DOI:10.1158/1078-0432.CCR-09-0377

Perspective

  • Perspective
    Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008
    Paul Okunieff, Lisa A. Kachnic, Louis S. Constine, Clifton D. Fuller, Laurie E. Gaspar, Daniel F. Hayes, Jean Hooks, Clifton Ling, Frank L. Meyskens Jr., Philip A. Philip, David Raben, Stephen R. Smalley, Gregory P. Swanson, Beverly A. Teicher, Charles R. Thomas Jr., Bhadrasain Vikram, Michael J. Zelefsky and Laurence H. Baker
    Clin Cancer Res September 15 2009 15 (18) 5663-5670; DOI:10.1158/1078-0432.CCR-09-0357

Review

  • Review
    Guiding the Optimal Translation of New Cancer Treatments From Canine to Human Cancer Patients
    Chand Khanna, Cheryl London, David Vail, Christina Mazcko and Steven Hirschfeld
    Clin Cancer Res September 15 2009 15 (18) 5671-5677; DOI:10.1158/1078-0432.CCR-09-0719

Human Cancer Biology

  • Human Cancer Biology
    Wnt Antagonist Gene DKK2 Is Epigenetically Silenced and Inhibits Renal Cancer Progression through Apoptotic and Cell Cycle Pathways
    Hiroshi Hirata, Yuji Hinoda, Koichi Nakajima, Ken Kawamoto, Nobuyuki Kikuno, Kazumori Kawakami, Soichiro Yamamura, Koji Ueno, Shahana Majid, Sharanjot Saini, Nobuhisa Ishii and Rajvir Dahiya
    Clin Cancer Res September 15 2009 15 (18) 5678-5687; DOI:10.1158/1078-0432.CCR-09-0558

  • Human Cancer Biology
    Putative Tumor-Suppressive Function of Krüppel-Like Factor 4 in Primary Lung Carcinoma
    Wenxian Hu, Wayne L. Hofstetter, Hong Li, Yanbin Zhou, Yong He, Abujiang Pataer, Li Wang, Keping Xie, Stephen G. Swisher and Bingliang Fang
    Clin Cancer Res September 15 2009 15 (18) 5688-5695; DOI:10.1158/1078-0432.CCR-09-0310

  • Human Cancer Biology
    Clinical and Biological Significance of CDK4 Amplification in Well-Differentiated and Dedifferentiated Liposarcomas
    Antoine Italiano, Laurence Bianchini, Elisabet Gjernes, Frédérique Keslair, Dominique Ranchere-Vince, Jean-Marc Dumollard, Juliette Haudebourg, Agnès Leroux, Claire Mainguené, Philippe Terrier, Frédéric Chibon, Jean-Michel Coindre and Florence Pedeutour
    Clin Cancer Res September 15 2009 15 (18) 5696-5703; DOI:10.1158/1078-0432.CCR-08-3185

  • Human Cancer Biology
    C-Raf Is Associated with Disease Progression and Cell Proliferation in a Subset of Melanomas
    Lucia B. Jilaveanu, Christopher R. Zito, Saadia A. Aziz, Patricia J. Conrad, John C. Schmitz, Mario Sznol, Robert L. Camp, David L. Rimm and Harriet M. Kluger
    Clin Cancer Res September 15 2009 15 (18) 5704-5713; DOI:10.1158/1078-0432.CCR-09-0198

  • Human Cancer Biology
    Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer
    Soundararajan Krishnaswamy, Rajani Kanteti, Jonathan S. Duke-Cohan, Sivakumar Loganathan, Wanqing Liu, Patrick C. Ma, Martin Sattler, Patrick A. Singleton, Nithya Ramnath, Federico Innocenti, Dan L. Nicolae, Zheng Ouyang, Jie Liang, John Minna, Mark F. Kozloff, Mark K. Ferguson, Viswanathan Natarajan, Yi-Ching Wang, Joe G.N. Garcia, Everett E. Vokes and Ravi Salgia
    Clin Cancer Res September 15 2009 15 (18) 5714-5723; DOI:10.1158/1078-0432.CCR-09-0070

  • Human Cancer Biology
    Phosphatidylinositol 3′-Kinase Catalytic Subunit α Gene Amplification Contributes to the Pathogenesis of Mantle Cell Lymphoma
    Amanda Psyrri, Sotirios Papageorgiou, Elisavet Liakata, Andreas Scorilas, Dimitra Rontogianni, Christos K. Kontos, Pinelopi Argyriou, Dimitrios Pectasides, Nikolaos Harhalakis, Vassiliki Pappa, Aggeliki Kolialexi, Christina Economopoulou, Frida Kontsioti, Eirini Maratou, George Dimitriadis, Panagiota Economopoulou and Theofanis Economopoulos
    Clin Cancer Res September 15 2009 15 (18) 5724-5732; DOI:10.1158/1078-0432.CCR-08-3215

  • Human Cancer Biology
    Impairment of Plasmacytoid Dendritic Cells for IFN Production by the Ligand for Immunoglobulin-Like Transcript 7 Expressed on Human Cancer Cells
    Nobuo Tsukamoto, Starlyn Okada, Yoko Onami, Yusuke Sasaki, Kazuo Umezawa and Yutaka Kawakami
    Clin Cancer Res September 15 2009 15 (18) 5733-5743; DOI:10.1158/1078-0432.CCR-09-0171

  • Human Cancer Biology
    MicroRNA Expression Signatures in Barrett's Esophagus and Esophageal Adenocarcinoma
    Hushan Yang, Jian Gu, Kenneth K. Wang, Wei Zhang, Jinliang Xing, Zhinan Chen, Jaffer A. Ajani and Xifeng Wu
    Clin Cancer Res September 15 2009 15 (18) 5744-5752; DOI:10.1158/1078-0432.CCR-09-0385

  • Human Cancer Biology
    EGFRvIII Deletion Mutations in Pediatric High-Grade Glioma and Response to Targeted Therapy in Pediatric Glioma Cell Lines
    Dorine A. Bax, Nathalie Gaspar, Suzanne E. Little, Lynley Marshall, Lara Perryman, Marie Regairaz, Marta Viana-Pereira, Raisa Vuononvirta, Swee Y. Sharp, Jorge S. Reis-Filho, João N. Stávale, Safa Al-Sarraj, Rui M. Reis, Gilles Vassal, Andrew D.J. Pearson, Darren Hargrave, David W. Ellison, Paul Workman and Chris Jones
    Clin Cancer Res September 15 2009 15 (18) 5753-5761; DOI:10.1158/1078-0432.CCR-08-3210

  • Human Cancer Biology
    Decreased Poly(ADP-Ribosyl)ation of CTCF, a Transcription Factor, Is Associated with Breast Cancer Phenotype and Cell Proliferation
    France Docquier, Georgia-Xanthi Kita, Dawn Farrar, Parmjit Jat, Michael O'Hare, Igor Chernukhin, Svetlana Gretton, Adhip Mandal, Louise Alldridge and Elena Klenova
    Clin Cancer Res September 15 2009 15 (18) 5762-5771; DOI:10.1158/1078-0432.CCR-09-0329

  • Human Cancer Biology
    Molecular Analysis of Endometrial Tumorigenesis: Importance of Complex Hyperplasia Regardless of Atypia
    Taina T. Nieminen, Annette Gylling, Wael M. Abdel-Rahman, Kyösti Nuorva, Markku Aarnio, Laura Renkonen-Sinisalo, Heikki J. Järvinen, Jukka-Pekka Mecklin, Ralf Bützow and Päivi Peltomäki
    Clin Cancer Res September 15 2009 15 (18) 5772-5783; DOI:10.1158/1078-0432.CCR-09-0506

  • Human Cancer Biology
    Progesterone Inhibition of Wnt/β-Catenin Signaling in Normal Endometrium and Endometrial Cancer
    Yongyi Wang, Payman Hanifi-Moghaddam, Eline E. Hanekamp, Helenius J. Kloosterboer, Patrick Franken, Jos Veldscholte, Helena C. van Doorn, Patricia C. Ewing, J. Julie Kim, J. Anton Grootegoed, Curt W. Burger, Riccardo Fodde and Leen J. Blok
    Clin Cancer Res September 15 2009 15 (18) 5784-5793; DOI:10.1158/1078-0432.CCR-09-0814

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer
    Mohamed S. Arredouani, Bin Lu, Manoj Bhasin, Miriam Eljanne, Wen Yue, Juan-Miguel Mosquera, Glenn J. Bubley, Vivian Li, Mark A. Rubin, Towia A. Libermann and Martin G. Sanda
    Clin Cancer Res September 15 2009 15 (18) 5794-5802; DOI:10.1158/1078-0432.CCR-09-0911

  • Cancer Therapy: Preclinical
    Tramadol and Flurbiprofen Depress the Cytotoxicity of Cisplatin via Their Effects on Gap Junctions
    Bo He, Xuhui Tong, Lingzhi Wang, Qin Wang, Hua Ye, Bing Liu, Xiaoting Hong, Liang Tao and Andrew L. Harris
    Clin Cancer Res September 15 2009 15 (18) 5803-5810; DOI:10.1158/1078-0432.CCR-09-0811

  • Cancer Therapy: Preclinical
    Candidate Biomarkers of Response to an Experimental Cancer Drug Identified through a Large-scale RNA Interference Genetic Screen
    Jasper Mullenders, Wolfgang von der Saal, Miranda M.W. van Dongen, Ulrike Reiff, Rogier van Willigen, Roderick L. Beijersbergen, Georg Tiefenthaler, Christian Klein and René Bernards
    Clin Cancer Res September 15 2009 15 (18) 5811-5819; DOI:10.1158/1078-0432.CCR-09-0261

  • Cancer Therapy: Preclinical
    Induction of Bim Expression Contributes to the Antitumor Synergy Between Sorafenib and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Inhibitor CI-1040 in Hepatocellular Carcinoma
    Da-Liang Ou, Ying-Chun Shen, Ja-Der Liang, Jun-Yang Liou, Sung-Liang Yu, Hsiang-Hsuan Fan, Da-Sheng Wang, Yen-Shen Lu, Chiun Hsu and Ann-Lii Cheng
    Clin Cancer Res September 15 2009 15 (18) 5820-5828; DOI:10.1158/1078-0432.CCR-08-3294

  • Cancer Therapy: Preclinical
    High-Dose Zoledronic Acid Impacts Bone Remodeling with Effects on Osteoblastic Lineage and Bone Mechanical Properties
    Samantha Pozzi, Sonia Vallet, Siddhartha Mukherjee, Diana Cirstea, Nileshwari Vaghela, Loredana Santo, Eyal Rosen, Hiroshi Ikeda, Yutaka Okawa, Tanyel Kiziltepe, Jesse Schoonmaker, Wanling Xie, Teru Hideshima, Edie Weller, Mary L. Bouxsein, Nikhil C. Munshi, Kenneth C. Anderson and Noopur Raje
    Clin Cancer Res September 15 2009 15 (18) 5829-5839; DOI:10.1158/1078-0432.CCR-09-0426

  • Cancer Therapy: Preclinical
    Cancer-Selective Targeting and Cytotoxicity by Liposomal-Coupled Lysosomal Saposin C Protein
    Xiaoyang Qi, Zhengtao Chu, Yonatan Y. Mahller, Keith F. Stringer, David P. Witte and Timothy P. Cripe
    Clin Cancer Res September 15 2009 15 (18) 5840-5851; DOI:10.1158/1078-0432.CCR-08-3285

  • Cancer Therapy: Preclinical
    Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells
    Eric Yvon, Michele Del Vecchio, Barbara Savoldo, Valentina Hoyos, Aurélie Dutour, Andrea Anichini, Gianpietro Dotti and Malcolm K. Brenner
    Clin Cancer Res September 15 2009 15 (18) 5852-5860; DOI:10.1158/1078-0432.CCR-08-3163

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Metabolic Tumor Volume of [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Short-Term Outcome to Radiotherapy With or Without Chemotherapy in Pharyngeal Cancer
    Man Ki Chung, Han-Sin Jeong, Sang Gyu Park, Jeon Yeob Jang, Young-Ik Son, Joon Young Choi, Seung Hyup Hyun, Keunchil Park, Myung-Ju Ahn, Yong Chan Ahn, Hyung-Jin Kim, Young-Hyeh Ko and Chung-Hwan Baek
    Clin Cancer Res September 15 2009 15 (18) 5861-5868; DOI:10.1158/1078-0432.CCR-08-3290

  • Imaging, Diagnosis, Prognosis
    Circulating Levels of Soluble KIT Serve as a Biomarker for Clinical Outcome in Gastrointestinal Stromal Tumor Patients Receiving Sunitinib following Imatinib Failure
    Samuel E. DePrimo, Xin Huang, Martin E. Blackstein, Christopher R. Garrett, Charles S. Harmon, Patrick Schöffski, Manisha H. Shah, Jaap Verweij, Charles M. Baum and George D. Demetri
    Clin Cancer Res September 15 2009 15 (18) 5869-5877; DOI:10.1158/1078-0432.CCR-08-2480

  • Imaging, Diagnosis, Prognosis
    Association of Inflammation-Related and microRNA Gene Expression with Cancer-Specific Mortality of Colon Adenocarcinoma
    Aaron J. Schetter, Giang Huong Nguyen, Elise D. Bowman, Ewy A. Mathé, Siu Tsan Yuen, Jason E. Hawkes, Carlo M. Croce, Suet Yi Leung and Curtis C. Harris
    Clin Cancer Res September 15 2009 15 (18) 5878-5887; DOI:10.1158/1078-0432.CCR-09-0627

  • Imaging, Diagnosis, Prognosis
    Low p27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor–Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy
    Martin Filipits, Margaretha Rudas, Harald Heinzl, Raimund Jakesz, Ernst Kubista, Sigurd Lax, Walter Schippinger, Otto Dietze, Richard Greil, Wolfgang Stiglbauer, Werner Kwasny, Alexander Nader, Michael Stierer, Michael F.X. Gnant and for the Austrian Breast and Colorectal Cancer Study Group
    Clin Cancer Res September 15 2009 15 (18) 5888-5894; DOI:10.1158/1078-0432.CCR-09-0728

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    A Multi-Institutional Phase II Study of the Efficacy and Tolerability of Lapatinib in Patients with Advanced Hepatocellular Carcinomas
    Tanios Bekaii-Saab, Joseph Markowitz, Nichole Prescott, Wolfgang Sadee, Nyla Heerema, Lai Wei, Zunyan Dai, Audrey Papp, Angela Campbell, Kristy Culler, Catherine Balint, Bert O'Neil, Ruey-min Lee, Mark Zalupski, Janet Dancey, Helen Chen, Michael Grever, Charis Eng and Miguel Villalona-Calero
    Clin Cancer Res September 15 2009 15 (18) 5895-5901; DOI:10.1158/1078-0432.CCR-09-0465

  • Cancer Therapy: Clinical
    Molecular Target Modulation, Imaging, and Clinical Evaluation of Gastrointestinal Stromal Tumor Patients Treated with Sunitinib Malate after Imatinib Failure
    George D. Demetri, Michael C. Heinrich, Jonathan A. Fletcher, Christopher D.M. Fletcher, Annick D. Van den Abbeele, Christopher L. Corless, Cristina R. Antonescu, Suzanne George, Jeffrey A. Morgan, Ming Hui Chen, Carlo L. Bello, Xin Huang, Darrel P. Cohen, Charles M. Baum and Robert G. Maki
    Clin Cancer Res September 15 2009 15 (18) 5902-5909; DOI:10.1158/1078-0432.CCR-09-0482

  • Cancer Therapy: Clinical
    A Phase I Study of Single-Agent Nilotinib or in Combination with Imatinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors
    George D. Demetri, Paolo G. Casali, Jean-Yves Blay, Margaret von Mehren, Jeffrey A. Morgan, Rossella Bertulli, Isabelle Ray-Coquard, Philippe Cassier, Monica Davey, Hossein Borghaei, Daniel Pink, Maria Debiec-Rychter, Wing Cheung, Stuart M. Bailey, Maria Luisa Veronese, Annette Reichardt, Elena Fumagalli and Peter Reichardt
    Clin Cancer Res September 15 2009 15 (18) 5910-5916; DOI:10.1158/1078-0432.CCR-09-0542

  • Cancer Therapy: Clinical
    The Potential Role of Curcumin in Patients with Monoclonal Gammopathy of Undefined Significance—Its Effect on Paraproteinemia and the Urinary N-Telopeptide of Type I Collagen Bone Turnover Marker
    Terry Golombick, Terrence H. Diamond, Vladimir Badmaev, Arumugam Manoharan and Rajeev Ramakrishna
    Clin Cancer Res September 15 2009 15 (18) 5917-5922; DOI:10.1158/1078-0432.CCR-08-2217

  • Cancer Therapy: Clinical
    Immunogenicity of the Hu14.18-IL2 Immunocytokine Molecule in Adults With Melanoma and Children With Neuroblastoma
    Jacquelyn A. Hank, Jacek Gan, Hyunji Ryu, Amy Ostendorf, Michael C. Stauder, Adam Sternberg, Mark Albertini, Kin-Ming Lo, Stephen D. Gillies, Jens Eickhoff and Paul M. Sondel
    Clin Cancer Res September 15 2009 15 (18) 5923-5930; DOI:10.1158/1078-0432.CCR-08-2963

  • Cancer Therapy: Clinical
    Interaction of Molecular Markers and Physical Activity on Mortality in Patients with Colon Cancer
    Jeffrey A. Meyerhardt, Shuji Ogino, Gregory J. Kirkner, Andrew T. Chan, Brian Wolpin, Kimmie Ng, Katsuhiko Nosho, Kaori Shima, Edward L. Giovannucci, Massimo Loda and Charles S. Fuchs
    Clin Cancer Res September 15 2009 15 (18) 5931-5936; DOI:10.1158/1078-0432.CCR-09-0496

  • Cancer Therapy: Clinical
    A Phase I Trial of Immunotherapy with Lapuleucel-T (APC8024) in Patients with Refractory Metastatic Tumors that Express HER-2/neu
    Prema P. Peethambaram, Michelle E. Melisko, Kristine J. Rinn, Steven R. Alberts, Nicole M. Provost, Lori A. Jones, Robert B. Sims, Lisa R. C. Lin, Mark W. Frohlich and John W. Park
    Clin Cancer Res September 15 2009 15 (18) 5937-5944; DOI:10.1158/1078-0432.CCR-08-3282

Back to top
PreviousNext
Clinical Cancer Research: 15 (18)
September 2009
Volume 15, Issue 18
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author

Sign up for alerts

Issue Highlights

  • Inhibition of ALK Signaling for Cancer Therapy
  • From the Editor
  • Molecular Target Modulation, Imaging, and Clinical Evaluation of Gastrointestinal Stromal Tumor Patients Treated with Sunitinib Malate after Imatinib Failure
  • Decreased Poly(ADP-Ribosyl)ation of CTCF, a Transcription Factor, Is Associated with Breast Cancer Phenotype and Cell Proliferation

Jump to

  • CCR Translations
  • Molecular Pathways
  • CCR Special Focus
  • Perspective
  • Review
  • Human Cancer Biology
  • Cancer Therapy: Preclinical
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
Advertisement
  • Most Cited
  • Most Read
Loading
  • Hyperprogressive Disease with Anti-PD-1/PD-L1 Therapy
  • Multiplex Genome Editing to Generate Universal CAR T Cells
  • Integrated Safety Analysis of Urelumab
  • Genomics of Immunotherapy-Associated Hyperprogressors
  • Translational Genomics in Breast Cancer
More...
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement